HRAIN BIOTECHNOLOGY
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.
HRAIN BIOTECHNOLOGY
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.dashengbio.com
Total Employee:
101+
Status:
Active
Total Funding:
200 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Mobile Non Scaleable Content Nginx Microsoft Azure DNS DigiCert SSL Japanese Yen GeoTrust SSL Alibaba
Similar Organizations
AIUDO
AIUDO is a concept of home care that is born from a personal experience, for this reason, empathy is one of the pillars of their service.
AKUOS
Enabling humanity through the elimination of medical stigma
Aldea Children & Family Services
Aldea believes in a family’s most critical moments, the company of a trusted professional.
Antaa
Antaa connects all medical treatments and connect life in order to respond to the desire of doctors who want to save the lives of patients.
Arizona Humane Society
Arizona Humane Society saves the most vulnerable animals and enriches the lives of pets and people.
Axxes Saude
We do something very simple at Axxes Saude: we help people get the care they want, with the doctor of their choice, and when time is right!
Cannvalate
cannvalate is dedicated to improving the health and wellbeing of patients.
Medicilio - Cantieri Digitali Medtech
A Decentralised Hospital, where patients of all types can access a top quality treatment with no need to go to a physical hospital.
Cardioset Medical
Cardioset Medical is a group of people who strive to make a life-changing impact on patients suffering from heart failure lung edema.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ClexBio
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.
Community Health Impact Coalition
Community Health Impact Coalition(CHIC) is making professionalized community health workers a norm worldwide.
Digitouch Health
Digitouch Health aids in the management of cardiovascular health.
DoctorYou
DoctorYou means simple medical care - tailored to your needs, without long waiting times at the doctors office.
ERG Controls
We ensure maximum hand hygiene in hospitals and other public settings to minimize the transmission of infections.
FamiOne
FamiOne is creating a society that will support the future of couples who want to receive children.
GEXVal
GEXVal is to help patients and families fighting against orphan and intractable diseases
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Gybe
Gybe helps protect and improves water resources globally starting at the community and local level.
Hedvig
Hedvig is a new approach to insurance. It’s about freedom and being ok with your life, no matter what happens to you.
I.M.LAB
I.M.LAB develop innovative healthcare products to help people save mode lives.
I3 Precision
It's primary goal is to reduce medication errors, improve patient safety, and increase productivity for hospitals and pharmacies.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
K-Three
K-Three specializes in outcome-based commissioning, impact investing and impact management.
KAKEHASHI
KAKEHASHI, have a strong sense of responsibility and a sense of duty to seriously think and act actively in the future of medical care.
Mansystems
Mansystems is An innovative survivor is a leader in their field and innovates to keep creating value for their customer .
Marengo Therapeutics
Marengo Therapeutics is seeking professionals who are motivated to make a positive difference in patients’ lives.
MEDCARE
Medcare leads the sustainable society and medical systems by its cutting-edge, optimized mix of therapy and prevention measures.
MediAngels
To change the way health care is delivered globally.
MiaDNA
MiaDNA provides people with the genetic information they need to improve their lifestyle and living habits.
MiraBiologics
MiraBiologics is a companybring a miracle to medicine for the better future of people.
NanoHealth
NanoHealth is changing the face of urban health in India.
RENOS DATA
RENOS DATA engages in the evidence business and services.
SafeRide Health
SafeRide Health's mission is to restore access and dignity to care. We partner with the nation's leading Medicaid and Medicare plans.
Secondmuse Foundation
Secondmuse Foundation is to build a world with zero injustice and sustainable prosperity for everything, everyone, everywhere.
Sharemedical
Sharemedical providing useful services from the viewpoint of both medical professionals and patients, starting from medical applications.
Current Employees Featured
Investors List
Shenzhen Capital Group
Shenzhen Capital Group investment in Series B - Hrain Biotechnology
ChiNext Qianhai Capital
ChiNext Qianhai Capital investment in Series B - Hrain Biotechnology
Junchenda Capital
Junchenda Capital investment in Series B - Hrain Biotechnology
Official Site Inspections
http://www.dashengbio.com Semrush global rank: 7.78 M Semrush visits lastest month: 437
- Host name: 47.97.102.159
- IP address: 47.97.102.159
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Hrain Biotechnology" on Search Engine
Hrain Biotechnology Company Profile 2024: Valuation, Funding ...
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Information on valuation, funding, cap tables, …See details»
Hrain Biotechnology Company Profile - Craft
Hrain Biotechnology (恒润达生) is a pharmaceutical company. It is engaged in the development of tumor immunotherapy technologies. Type. Private. Status. Active. …See details»
Hrain Biotech Raises $28 Million in B Round for …
Shanghai Hrain Biotechnology, a clinical-stage oncology immunotherapy company, raised $28 million in a Series B round led by Shenzhen …See details»
HRAIN BIOTECHNOLOGY | LinkedIn
Hrain is supported by authoritative scientific advisory committee, cooperating with international top universities and domestic research institutes, including University of …See details»
Hrain Biotechnology - Products, Competitors, Financials, …
Overview & Products. Financials. People. Founded Year. 2015. Stage. Series C | Alive. Total Raised. $57.21M. About Hrain Biotechnology. Hrain Biotechnology is a …See details»
Hrain Biotech Raises $28 Million in B Round for Immunotherapies
Oct 1, 2019 Shanghai Hrain Biotechnology, a clinical-stage oncology immunotherapy company, raised $28 million in a Series B round led by Shenzhen Capital. Hrain is …See details»
Hrain Biotech Plans $352 Million Shanghai STAR IPO for Novel …
Publication date: Oct 19, 2022. Shanghai Hrain Biotechnology will stage an IPO on Shanghai’s STAR board that is expected to raise $352 million for its cell therapy …See details»
China Digest: Hrain Biotech raises $29m Series B+; Qiming leads …
Liya Su. 09 September, 2020. Hrain Biotechnology has pocketed 200 million yuan ($29 million) in a Series B+ round, while Weier Technology has raised “tens of millions of US …See details»
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy …
Hrain Biotechnology Co., Ltd. ClinicalTrials.gov Identifier: NCT05436223 Other Study ID Numbers: HRAIN01-NHL01-Ⅱ : First Posted: June 29, 2022 Key Record Dates: Last …See details»
Hrain Biotechnology | VentureRadar
Location: China. Develops innovative tumor immunotherapy technologies, focusing on enhancing cancer treatment through cutting-edge biotechnology research and …See details»
Anti-BCMA bispecific chimeric antigen receptor T cell therapy
Sep 27, 2023 09 Feb 2022 Hrain Biotechnology initiates phase-I trial for Multiple myeloma (Second-line therapy or greater) in China (IV) (NCT05302648)See details»
Hrain Biotechnology Co. Ltd. - Drug pipelines, Patents, Clinical …
Explore Hrain Biotechnology Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 25 clinical trials, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, …See details»
Organization | Hrain Biotechnology Co., Ltd. - CDEK
Organization Overview. First Clinical Trial. 2018 NCT04303520. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Hrain Biotechnology Co., Ltd. Active …See details»
Hrain Biotechnology (恒润达生) - Tech in Asia
Shanghai, China. Medical. 51 – 200. Hrain Biotechnology (恒润达生) is a technology company that focuses on R&D and application of tumor immunotherapy technologies …See details»
Anti-CD19 anti-BCMA bispecific chimeric antigen receptor T
Drug Profile. Anti-CD19 anti-BCMA bispecific chimeric antigen receptor T cell therapy - Hrain Biotechnology. Alternative Names: Anti-CD19/BCMA bispecific CAR T cell …See details»
Organization | Hrain Biotechnology Co., Ltd. - CDEK
Organization Overview. First Clinical Trial. 2018. NCT04303520. First Marketed Drug. None. First NDA Approval. None. Last Known Activity. 2023. Timeline. Acquisitions. Trial …See details»
Google helped make an exquisitely detailed map of a tiny piece of …
1 day ago A team led by scientists from Harvard and Google has created a 3D, nanoscale-resolution map of a single cubic millimeter of the human brain. Although the map covers …See details»
Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news
8 hours ago Sanofi reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a …See details»
Anti CD19 chimeric antigen receptor T cell therapy - HRAIN …
At a glance. Originator Hrain Biotechnology. Developer Fudan University Zhongshan Hospital; HRAIN Biotechnology; Shanghai Changzheng Hospital; Shanghai General …See details»
Anti-CD19 anti-CD22 bispecific chimeric antigen receptor T
A retroviral vector-transduced autologous chimeric antigen receptor T (CAR-T) cell therapy targeting CD 19 and CD 22 antigen, is being developed by Hrain Anti-CD19 anti-CD22 …See details»